CXCL9 and neoplasm: Mettl3- or Mettl14-deficient tumors increased cytotoxic tumor-infiltrating CD8+ T cells and elevated secretion of IFN-c, Cxcl9, and Cxcl10 in tumor microenvironment in vivo (19).